VINORELBINE AG vinorelbine (as tartrate) 10 mg/1 mL concentrated injection vial

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

vinorelbine tartrate, Quantity: 13.85 mg (Equivalent: vinorelbine, Qty 10 mg)

Disponibbli minn:

MedTAS Pty Ltd

INN (Isem Internazzjonali):

Vinorelbine tartrate

Għamla farmaċewtika:

Injection, concentrated

Kompożizzjoni:

Excipient Ingredients: water for injections

Rotta amministrattiva:

Intravenous Infusion

Unitajiet fil-pakkett:

Pack of 1 x 1 mL vial, Pack of 10 x 1 mL vials, Pack of 5 x 1 mL vials

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Sommarju tal-prodott:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2012-01-18